英国临床实践中精神病性障碍或双相障碍风险的联合检测:临床预测模型的开发与验证
本研究基于英国SLaM电子健康记录开发并验证了一个跨诊断临床预测模型,用于联合估计非器质性、非精神病性、非双相精神障碍患者6年内发展为精神病性障碍或双相障碍的风险。
要点
- 模型纳入社会人口学、临床、药物、住院及自然语言处理衍生的症状与物质使用等预测因子。
核心结论
- 跨诊断临床预测模型可识别精神病性障碍或双相障碍高风险患者,并表现出色。
研究设计与样本
- 使用2008年1月1日至2021年8月10日英国SLaM二级精神卫生保健电子健康记录数据开发并验证临床预测模型。
- 纳入所有年龄、索引诊断为非器质性、非精神病性、非双相精神障碍的患者,共127 868例。
- 采用LASSO正则化Cox比例风险模型估计6年风险,通过内部-外部验证评估性能。
主要发现
- 决策曲线分析显示,每筛查100例患者,使用该模型比默认评估策略额外早期检出3例精神病性障碍或双相障碍。
关键数值与推荐
- 模型纳入索引日期时5个社会人口学与临床预测因子、4个药物预测因子、2个住院预测因子及66个自然语言处理衍生的症状与物质使用预测因子。
- 排除标准包括:双相或精神病性障碍诊断前接受长效注射抗精神病药或氯氮平、索引日期后无SLaM服务联系记录、索引日期在2008年1月1日至2008年6月30日洗脱期内。
临床怎么用
- 该模型可用于系统性地早期检测精神病性障碍或双相障碍高风险年轻人,推进真实临床实践中的预防性照护。
局限性
- 有双相障碍或精神病性障碍亲历经验者未参与研究或写作过程。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Efficient detection of individuals at risk of developing psychotic disorders or bipolar disorders is a crucial step to improving mental health outcomes in young people. A novel, transdiagnostic approach to jointly detect individuals at risk for either psychotic disorders or bipolar disorders would maximise the effect of prevention. The aim of this study is to develop and validate an individualised prediction model to detect the risk of developing psychotic disorders or bipolar disorders in the UK. METHODS: This RECORD Statement and TRIPOD+AI compliant study describes the development and validation of a clinical prediction model to estimate the risk of developing psychotic or bipolar disorders using data from patients of all ages with an index diagnosis of a non-organic, non-psychotic and non-bipolar mental disorder recorded in electronic health records from South London and Maudsley (SLaM in the UK) secondary mental health care between Jan 1, 2008, and Aug 10, 2021. Exclusion criteria included receiving long-acting injectable antipsychotics or clozapine before a diagnosis of bipolar or psychotic disorders, no recorded contact with SLaM services after the index date, and an index date falling within the washout period Jan 1, 2008, to June 30, 2008. A least absolute shrinkage and selection operator-regularised (LASSO) Cox proportional hazards model was developed to estimate the 6-year risk of developing psychotic disorders or bipolar disorders, incorporating sociodemographic and clinical predictors at index date (five predictors), and medication (four predictors), hospitalisation (two predictors) and natural language processing-derived signs and symptoms and substance use (66 predictors), derived using a 6-month look-back period. Model performance was assessed using internal-external validation, sequentially leaving out one borough from the SLaM area for testing and averaging performance across all five boroughs. The final model was fit with data across all the boroughs. Performance was assessed via discrimination (C-index), calibration (calibration slope and calibration-in-the-large), and potential clinical utility (decision curve analysis) during internal-external cross-validation. Individuals with lived experience of bipolar disorders or psychotic disorders were not involved in the research or writing process. FINDINGS: In total, data from 127 868 patients were included. 64 980 (50·8%) of the dataset were male, 62 711 (49·0%) were female, and 89 (0·1%) were other gender. For self-assigned ethnicity, the dataset was 71 390 (55·8%) White, 18 025 (14·1%) Black, 7257 (5·7%) other, 6270 (4·9%) Asian, and 5022 (3·9%) mixed (19 904 [15·6%] were missing ethnicity data). The mean age was 33·4 years (SD 18·8 [IQR 17·9-44·9]). The cumulative risk incidence of psychotic disorders or bipolar disorders was 0·0827 (95% CI 0·0784-0·0870) within 6 years (mean follow-up 622 days [SD 687]). The model showed the following performance in internal-external validation: C-index 0·80 (95% CI 0·78-0·81); calibration slope 1·02 (SD 0·14); calibration-in-the-large 0·06 (SD 0·02). Decision curve analysis showed that use of the model would detect three additional cases of psychotic disorders or bipolar disorders early per 100 patients screened compared with default assessment strategies. INTERPRETATION: This study shows that the transdiagnostic clinical prediction model can identify patients at risk of developing psychotic disorders or bipolar disorders and displayed excellent performance. Such a novel approach would enable systematic early detection of young people at risk of psychotic disorders or bipolar disorders, advancing preventive care in real-world clinical practice. FUNDING: UK Medical Research Council (MR/N013700/1), National Institute for Health Research (NIHR) Biomedical Research Centres at South London and Maudsley NHS Foundation Trust, and Oxford Health NHS Foundation Trust.
引用
- Arribas M, de Micheli A, Krakowski K, et al. Joint detection of risk for psychotic disorders or bipolar disorders in clinical practice in the UK: development and validation of a clinical prediction model. Lancet Psychiatry. 2025. PMID: 41317739. doi:10.1016/S2215-0366(25)00307-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。